Thymosin Alpha-1
Thymosin Alpha-1 (Thymalfasin)
The immune modulator
A 28-amino-acid peptide naturally produced by the thymus gland. Thymosin Alpha-1 is one of the most clinically validated peptides in existence — approved in over 35 countries for hepatitis B/C and as an immune adjuvant. It enhances T-cell maturation, dendritic cell function, and bridges innate and adaptive immunity.
Key Benefits
Enhanced T-cell maturation and immune surveillance
Improved dendritic cell antigen presentation
Increased natural killer cell activity
Immune restoration in immunocompromised states
Adjuvant effect when combined with vaccines
Mechanism of Action
How Thymosin Alpha-1 works
Thymosin Alpha-1 orchestrates immune function through multiple coordinated mechanisms:
- T-cell maturation — promotes differentiation of immature T-cells (thymocytes) into functional CD4+ and CD8+ cells, restoring immune surveillance that declines with thymic involution after age 30
- Dendritic cell activation — stimulates dendritic cell maturation and antigen presentation via TLR9 signaling, improving the immune system's ability to identify and respond to threats
- NK cell enhancement — increases natural killer cell cytotoxicity, the first-line defense against virus-infected and abnormal cells
- Cytokine balancing — modulates IL-2, IFN-alpha, and IFN-gamma production without overstimulating inflammatory cascades, making it immunomodulatory rather than purely immunostimulatory
Your Genetics & Thymosin Alpha-1
Genetic variants that affect your response
These SNPs determine how effectively Thymosin Alpha-1 works for you specifically. A genetic peptide report identifies your variants before you start.
HLA-DRB1 variants determine which antigens your immune system can recognize. Certain alleles are associated with weaker viral clearance — Thymosin Alpha-1's dendritic cell enhancement may compensate for suboptimal antigen presentation.
The -308G>A promoter polymorphism increases TNF-alpha production. High TNF producers may experience stronger initial immune activation with Thymosin Alpha-1, but its modulatory effect helps prevent overactivation.
Affects IL-2 production, the primary growth factor for T-cells. Low IL-2 producers may see greater benefit from Thymosin Alpha-1's ability to upregulate IL-2 signaling and T-cell expansion.
TLR9 is the receptor through which Thymosin Alpha-1 activates dendritic cells. The -1237T>C variant affects TLR9 expression — carriers of the C allele may have altered dendritic cell response to Thymosin Alpha-1.
Which variants do you carry?
Upload your DNA data or order a kit to find out.
Evidence & Research
200+
Published studies
Multiple human clinical trials or CPIC-level pharmacogenomic data
Common Stacks
Thymosin Alpha-1 is commonly combined with:
Frequently Asked Questions
What is Thymosin Alpha-1 used for?
Thymosin Alpha-1 is used to enhance immune function. It is FDA-approved in over 35 countries (as Zadaxin) for chronic hepatitis B and C, and used as an immune adjuvant in cancer immunotherapy. It restores T-cell function, enhances dendritic cell activity, and is particularly valuable for age-related immune decline.
Does genetics affect Thymosin Alpha-1 response?
Yes. HLA-DRB1 variants affect antigen presentation efficiency, TNF-alpha variants influence baseline inflammatory tone, and IL-2 variants determine T-cell proliferation capacity. Genetic testing identifies whether your immune system has specific gaps that Thymosin Alpha-1 is best positioned to fill.
Is Thymosin Alpha-1 safe?
Thymosin Alpha-1 has one of the strongest safety profiles of any peptide. It has been used in clinical settings for over 30 years with minimal side effects. Its immunomodulatory (not immunostimulatory) nature means it enhances immune function without triggering dangerous overactivation.
Personalize your protocol
Does Thymosin Alpha-1 match your DNA?
Upload your existing genetic data or order a kit. Your report scores Thymosin Alpha-1 against your unique genetic profile — CYP metabolism, receptor variants, pathway markers — in minutes.